These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31029655)

  • 61. Factors hindering access to abortion services.
    Henshaw SK
    Fam Plann Perspect; 1995; 27(2):54-9, 87. PubMed ID: 7796896
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Young age and termination of pregnancy during the second trimester are risk factors for repeat second-trimester abortion.
    Mentula MJ; Niinimäki M; Suhonen S; Hemminki E; Gissler M; Heikinheimo O
    Am J Obstet Gynecol; 2010 Aug; 203(2):107.e1-7. PubMed ID: 20435289
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Provision of intrauterine contraception in association with first trimester induced abortion reduces the need of repeat abortion: first-year results of a randomized controlled trial.
    Pohjoranta E; Mentula M; Gissler M; Suhonen S; Heikinheimo O
    Hum Reprod; 2015 Nov; 30(11):2539-46. PubMed ID: 26370664
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rates of follow-up and repeat pregnancy in the 12 months after first-trimester induced abortion.
    Madden T; Westhoff C
    Obstet Gynecol; 2009 Mar; 113(3):663-668. PubMed ID: 19300332
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Second-trimester abortion and risk of live birth.
    Auger N; Brousseau É; Ayoub A; Fraser WD
    Am J Obstet Gynecol; 2024 Jun; 230(6):679.e1-679.e9. PubMed ID: 37939985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predictors of delay in each step leading to an abortion.
    Foster DG; Jackson RA; Cosby K; Weitz TA; Darney PD; Drey EA
    Contraception; 2008 Apr; 77(4):289-93. PubMed ID: 18342653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Healthcare costs for abortions performed in ambulatory surgery centers vs office-based settings.
    Leslie DL; Liu G; Jones BS; Roberts SCM
    Am J Obstet Gynecol; 2020 Apr; 222(4):348.e1-348.e9. PubMed ID: 31629727
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
    Nissi R; Santala M; Immonen E; Talvensaari-Mattila A
    Arch Gynecol Obstet; 2016 Nov; 294(6):1243-1247. PubMed ID: 27522599
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety and acceptability of medical abortion through telemedicine after 9 weeks of gestation: a population-based cohort study.
    Endler M; Beets L; Gemzell Danielsson K; Gomperts R
    BJOG; 2019 Apr; 126(5):609-618. PubMed ID: 30456778
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The duration of gestation at previous induced abortion and its impacts on subsequent births: A nationwide registry-based study.
    Kc S; Gissler M; Klemetti R
    Acta Obstet Gynecol Scand; 2020 May; 99(5):651-659. PubMed ID: 32128786
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk factors for legal induced abortion-related mortality in the United States.
    Bartlett LA; Berg CJ; Shulman HB; Zane SB; Green CA; Whitehead S; Atrash HK
    Obstet Gynecol; 2004 Apr; 103(4):729-37. PubMed ID: 15051566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy--a randomized trial.
    Mentula M; Suhonen S; Heikinheimo O
    Hum Reprod; 2011 Oct; 26(10):2690-7. PubMed ID: 21798991
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Surgical termination of pregnancy for fetal anomaly: what role can an independent abortion service provider play?
    Callaby H; Fisher J; Lohr PA
    J Obstet Gynaecol; 2019 Aug; 39(6):799-804. PubMed ID: 30999795
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intravenous Sedation Without Intubation and the Risk of Anesthesia Complications for Obese and Non-Obese Women Undergoing Surgical Abortion: A Retrospective Cohort Study.
    Gokhale P; Lappen JR; Waters JH; Perriera LK
    Anesth Analg; 2016 Jun; 122(6):1957-62. PubMed ID: 27177015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Accompaniment of second-trimester abortions: the model of the feminist Socorrista network of Argentina.
    Zurbriggen R; Keefe-Oates B; Gerdts C
    Contraception; 2018 Feb; 97(2):108-115. PubMed ID: 28801052
    [TBL] [Abstract][Full Text] [Related]  

  • 77. One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16 weeks of gestation.
    Hou S; Zhang L; Chen Q; Fang A; Cheng L
    Int J Gynaecol Obstet; 2010 Nov; 111(2):126-30. PubMed ID: 20705290
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Second trimester pregnancy termination using extra-amniotic ethacridine lactate.
    Bhathena RK; Sheriar NK; Walvekar VR; Guillebaud J
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1026-9. PubMed ID: 2123711
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reasons for second trimester abortions in England and Wales.
    Ingham R; Lee E; Clements SJ; Stone N
    Reprod Health Matters; 2008 May; 16(31 Suppl):18-29. PubMed ID: 18772080
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The seasonality of abortion in Kentucky.
    Franklin TE; Theisen G; Salyer CV; Pinkston C; Gunaratnam B
    Contraception; 2017 Feb; 95(2):181-185. PubMed ID: 27593333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.